Unanticipated improvement in seizure control in drug-resistant epilepsy-real world observations

被引:5
|
作者
Moloney, Patrick B. [1 ]
Costello, Daniel J. [1 ,2 ]
机构
[1] Cork Univ Hosp, Dept Neurol, Cork, Ireland
[2] Univ Coll Cork, Coll Med & Hlth, Cork, Ireland
来源
关键词
Drug-resistant epilepsy; Anti-seizure medication; Unanticipated treatment response; Rational polytherapy; QUALITY-OF-LIFE; ANTIEPILEPTIC DRUGS; ILAE COMMISSION; REMISSION; POPULATION; LACOSAMIDE; OUTCOMES; SURGERY; RELAPSE;
D O I
10.1016/j.seizure.2020.11.005
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: To determine the clinical features and anti-seizure medication (ASM) strategies associated with an unanticipated substantial improvement in seizure control in patients with drug-resistant epilepsy (DRE). Methods: This retrospective analysis of patients attending a tertiary care epilepsy clinic between 2008 and 2017 identified all patients with active DRE (at least 1 seizure per month for 6 months, despite treatment with 2 different ASMs). All treatment interventions were recorded from when DRE was first identified to the end of the study. The primary end points were seizure freedom or meaningful reduction in seizure frequency (greater than 75 %) sustained for at least 12 months after a treatment intervention. Results: Three hundred and twenty-two patients were included in the analysis. Overall, 10 % became seizure free following ASM adjustment and an additional 10 % had a greater than 75 % improvement in seizure control (median follow-up, 4 years). An ASM introduction was ten times more likely than an ASM dose increase to improve seizure control. Combined focal and generalized epilepsy, intellectual disability and prior treatment with more than 5 ASMs were more frequently observed in those with continued pharmacoresistance. ASM responders were more likely to have primary generalized epilepsy. Rational polytherapy (combining ASMs with different mechanisms of action) was almost ubiquitous amongst ASMs responders (95 % taking at least 2 drugs with different mechanistic targets). Of the ASM additions that heralded improved seizure control, 85 % were maintained at submaximal doses. Conclusions: This retrospective analysis of a large number of 'real-world' patients provides evidence to persist with ASM trials in DRE. Early rotation of ASMs if a clinical response is not observed at a substantial dose and rational ASM polytherapy may yield better clinical outcomes in patients with DRE, although a prospective study would need to be conducted to validate these findings.
引用
收藏
页码:60 / 65
页数:6
相关论文
共 50 条
  • [41] The efficacy of perampanel as adjunctive therapy in drug-resistant focal epilepsy in a "real world" context: focus on temporal lobe epilepsy
    Pascarella, Angelo
    Iannone, Luigi Francesco
    Di Gennaro, Giancarlo
    D'Aniello, Alfredo
    Ferlazzo, Edoardo
    Gagliostro, Nazareno
    Ursini, Francesco
    Bonanni, Paolo
    Paciello, Nicola
    Romigi, Andrea
    Aguglia, Umberto
    De Sarro, Giovambattista
    Russo, Emilio
    Gambardella, Antonio
    Labate, Angelo
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2020, 415
  • [42] Association between the Serum Coenzyme Q10 Level and Seizure Control in Patients with Drug-Resistant Epilepsy
    Liao, Wei-Chen
    Huang, Chin-Wei
    Hsiao, Ya-Hsin
    Sung, Pi-Shan
    Fu, Tzu-Fun
    Chang, Alice Y. W.
    Chang, Hui Hua
    HEALTHCARE, 2021, 9 (09)
  • [43] The dual effect of vagus nerve stimulation in pediatric patients with drug-resistant epilepsy: Is there more than seizure control?
    Mahmoud, Mohamed Ashraf
    El Rashidi, Omnia
    Halim, George
    Elkholy, Mohamed Amgad
    Aglan, Osama
    El Sabbagh, Abdel Rahman
    Basha, Ahmed Kamel
    Hamdi, Hussein
    El Sayed, Ahmed M.
    Saleh, Dina Amin
    Shatla, R. H.
    Ghany, Walid Abdel
    EPILEPSY & BEHAVIOR REPORTS, 2024, 27
  • [44] Late-life terminal seizure freedom in drug-resistant epilepsy: "Burned-out epilepsy"
    Rajakulendran, S.
    Belluzzo, M.
    Novy, J.
    Sisodiya, S. M.
    Koepp, M. J.
    Duncan, J. S.
    Sander, J. W.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 431
  • [45] Coping strategies in epilepsy: 50 drug-resistant and 50 seizure-free patients
    Piazzini, Ada
    Ramaglia, Giovanna
    Turner, Katherine
    Chifari, Rosanna
    El Kiky, Elisabeth
    Canger, Raffaele
    Canevini, Maria Paola
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2007, 16 (03): : 211 - 217
  • [46] Predictors of seizure reduction outcome after vagus nerve stimulation in drug-resistant epilepsy
    Wang, Hai-Jiao
    Tan, Ge
    Zhu, Li-na
    Chen, Deng
    Xu, Da
    Chu, Shan-shan
    Liu, Ling
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2019, 66 : 53 - 60
  • [47] The role of seizure video recordings in the diagnosis of referred drug-resistant epilepsy: A stepwise approach
    Nguyen, Duy Duan
    Tran, Thi Kim Anh
    Tran, Thi Phuoc Yen
    Pham, Quoc Nguyen Bao
    Nguyen, Toan Dinh
    EPILEPSY RESEARCH, 2025, 211
  • [48] SEIZURE OUTCOME AND PATHOLOGICAL CORRELATION IN DRUG-RESISTANT TEMPORAL LOBE EPILEPSY SURGICALLY TREATED
    Rubboli, G.
    Giulioni, M.
    Volpi, L.
    Martinoni, M.
    Riguzzi, P.
    Marucci, G.
    Marliani, A. F.
    Battaglia, S.
    Bisulli, F.
    Tinuper, P.
    Calbucci, F.
    Michelucci, R.
    EPILEPSIA, 2011, 52 : 191 - 191
  • [49] Metabolomic characterization of human hippocampus from drug-resistant epilepsy with mesial temporal seizure
    Detour, Julien
    Bund, Caroline
    Behr, Charles
    Cebula, Helene
    Cicek, Ercument A.
    Valenti-Hirsch, Maria-Paola
    Lannes, Beatrice
    Lhermitte, Benoit
    Nehlig, Astrid
    Kehrli, Pierre
    Proust, Francois
    Hirsch, Edouard
    Namer, Izzie-Jacques
    EPILEPSIA, 2018, 59 (03) : 607 - 616
  • [50] Short and long term prediction of seizure freedom in drug-resistant focal epilepsy surgery
    Santos-Santos, Aisel
    Morales-Chacon, Lilia Maria
    Galan-Garcia, Lidice
    Machado, Calixto
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2023, 230